Business
The two big challenges facing AstraZeneca’s vaccine – Sydney Morning Herald
New twists in the coronavirus pandemic have placed major challenges in front of Australia’s “ace in the hole” vaccine.
Second, the rise of variants appears to cut the efficacy of the vaccine. We still dont know by how much but we now have several points of human data, none of them positive. South Africa, where one variant runs rampant, has paused the rollout of the vaccine.
The government says it expects AstraZeneca to be approved for all age groups, and to still provide good protection against the South African variant.
Chief Medical Officer Professor Paul Kelly has advised that currently there is no evidence to…
-
Business24 hours agoThese ASX 200 shares could rise 15% to 20%
-
Business23 hours agoEvery ASX 200 sector closed in the red last week. Here’s why
-
Noosa News22 hours agoFervor Wines label started during pandemic keeps father and son close
-
General18 hours agoLambie, hypocrisy, and the misinformation & disinformation bill